Elevated levels of KCa3.1 (KCNN4) have been identified across a spectrum of malignant neoplasms, including pancreatic cancer 22, breast cancer 23, non-small cell lung cancer(NSCLC) 24, and melanoma 25. Here, KCNN4 is linked to breast carcinoma.